SEK 44.95
(1.24%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.71 Billion SEK | 15.14% |
2022 | 1.4 Billion SEK | 1.11% |
2021 | 879 Million SEK | 29.57% |
2020 | 904 Million SEK | 2.66% |
2019 | 636.8 Million SEK | 78.04% |
2018 | 511.2 Million SEK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 316 Million SEK | 8.79% |
2024 Q2 | 449 Million SEK | 30.64% |
2023 Q2 | 471 Million SEK | 24.27% |
2023 FY | - SEK | 15.14% |
2023 Q4 | 330 Million SEK | -25.34% |
2023 Q3 | 442 Million SEK | -6.16% |
2023 Q1 | 379 Million SEK | 232.46% |
2022 Q1 | 347 Million SEK | 96.05% |
2022 Q4 | 114 Million SEK | -67.89% |
2022 Q3 | 355 Million SEK | -3.27% |
2022 Q2 | 367 Million SEK | 5.76% |
2022 FY | - SEK | 1.11% |
2021 Q1 | 303 Million SEK | 83.92% |
2021 FY | - SEK | 29.57% |
2021 Q2 | 348 Million SEK | 14.85% |
2021 Q4 | 177 Million SEK | -48.55% |
2021 Q3 | 344 Million SEK | -1.15% |
2020 FY | - SEK | 2.66% |
2020 Q3 | 273 Million SEK | 39.29% |
2020 Q1 | 191.5 Million SEK | 0.0% |
2020 Q4 | 164.75 Million SEK | -39.65% |
2020 Q2 | 196 Million SEK | 2.35% |
2019 FY | - SEK | 78.04% |
2018 FY | - SEK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AddLife AB (publ) | 1.54 Billion SEK | -10.673% |
Biotage AB (publ) | 432 Million SEK | -296.065% |
Bonesupport Holding AB (publ) | 28.93 Million SEK | -5812.845% |
Doxa AB (publ) | 296 Million SEK | -478.041% |
Elekta AB (publ) | 3.29 Billion SEK | 48.01% |
iZafe Group AB (publ) | -15.61 Million SEK | 11056.009% |
Ortivus AB (publ) | -14.92 Million SEK | 11563.219% |
Ortivus AB (publ) | -14.92 Million SEK | 11563.219% |
Q-linea AB (publ) | -210.98 Million SEK | 910.954% |
S2Medical AB (publ) | -13.52 Million SEK | 12746.789% |